Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
This 100% virtual study recruited subjects digitally based on lower urinary tract symptoms and discomfort from an enlarged prostrate. ObvioHealth invited them to download our app to complete screening/enrollment, and study activities. The protocol required subjects to consume one capsule daily for twelve consecutive weeks, while reporting any noticeable changes to their health.
• Ease of reporting helped to achieve a 87% retention rate
• Efficacy was proven. Subjects reported the treatment helped to reduce symptoms of LUTS.
Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
This 100% virtual study recruited subjects digitally based on lower urinary tract symptoms and discomfort from an enlarged prostrate. ObvioHealth invited them to download our app to complete screening/enrollment, and study activities. The protocol required subjects to consume one capsule daily for twelve consecutive weeks, while reporting any noticeable changes to their health.
• Ease of reporting helped to achieve a 87% retention rate
• Efficacy was proven. Subjects reported the treatment helped to reduce symptoms of LUTS.
Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
This 100% virtual study recruited subjects digitally based on lower urinary tract symptoms and discomfort from an enlarged prostrate. ObvioHealth invited them to download our app to complete screening/enrollment, and study activities. The protocol required subjects to consume one capsule daily for twelve consecutive weeks, while reporting any noticeable changes to their health.
• Ease of reporting helped to achieve a 87% retention rate
• Efficacy was proven. Subjects reported the treatment helped to reduce symptoms of LUTS.
Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
This 100% virtual study recruited subjects digitally based on lower urinary tract symptoms and discomfort from an enlarged prostrate. ObvioHealth invited them to download our app to complete screening/enrollment, and study activities. The protocol required subjects to consume one capsule daily for twelve consecutive weeks, while reporting any noticeable changes to their health.
• Ease of reporting helped to achieve a 87% retention rate
• Efficacy was proven. Subjects reported the treatment helped to reduce symptoms of LUTS.
Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
This 100% virtual study recruited subjects digitally based on lower urinary tract symptoms and discomfort from an enlarged prostrate. ObvioHealth invited them to download our app to complete screening/enrollment, and study activities. The protocol required subjects to consume one capsule daily for twelve consecutive weeks, while reporting any noticeable changes to their health.
• Ease of reporting helped to achieve a 87% retention rate
• Efficacy was proven. Subjects reported the treatment helped to reduce symptoms of LUTS.
Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
This 100% virtual study recruited subjects digitally based on lower urinary tract symptoms and discomfort from an enlarged prostrate. ObvioHealth invited them to download our app to complete screening/enrollment, and study activities. The protocol required subjects to consume one capsule daily for twelve consecutive weeks, while reporting any noticeable changes to their health.
• Ease of reporting helped to achieve a 87% retention rate
• Efficacy was proven. Subjects reported the treatment helped to reduce symptoms of LUTS.
Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
Lycored, a multi-national supplement company, needed evidence for the efficacy of its Carotenoid-based supplement in relieving Lower Urinary Tract Symptoms (LUTS).
This 100% virtual study recruited subjects digitally based on lower urinary tract symptoms and discomfort from an enlarged prostrate. ObvioHealth invited them to download our app to complete screening/enrollment, and study activities. The protocol required subjects to consume one capsule daily for twelve consecutive weeks, while reporting any noticeable changes to their health.
• Ease of reporting helped to achieve a 87% retention rate
• Efficacy was proven. Subjects reported the treatment helped to reduce symptoms of LUTS.
ObvioHealth successfully conducted a clinical trial for RedHill Biopharma to test the safety and efficacy of an oral medication for the treatment of COVID-19 symptoms. We designed this decentralized study to be conducted where the majority of patients recover from illness—in their homes. When the trial was launched in 2021, its unique combination of home health visits, electronic patient-reported outcomes (ePRO), and remote monitoring devices was pioneering—COVID-19 studies were typically conducted inside hospitals.
ObvioHealth and Renovia conducted a groundbreaking study on the efficacy of an at-home medical device for the treatment of stress and mixed urinary incontinence. Read more below to understand how we delivered a successful, fully virtual clinical trial in the midst of the pandemic.